US HB5539 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on September 18 2023 - 25% progression
Action: 2023-09-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 18 2023 - 25% progression
Action: 2023-09-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XI of the Social Security Act to expand and clarify the exclusion for orphan drugs under the Drug Price Negotiation Program.
Title
ORPHAN Cures Act Optimizing Research Progress Hope And New Cures Act
Sponsors
Rep. John Joyce [R-PA] | Rep. Wiley Nickel [D-NC] | Rep. Donald Davis [D-NC] | Rep. Kevin Hern [R-OK] |
Rep. Scott Peters [D-CA] | Rep. Gus Bilirakis [R-FL] | Rep. Josh Gottheimer [D-NJ] | Rep. Lloyd Smucker [R-PA] |
Rep. Mariannette Miller-Meeks [R-IA] |
History
Date | Chamber | Action |
---|---|---|
2023-09-22 | House | Referred to the Subcommittee on Health. |
2023-09-18 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2023-09-18 | House | Introduced in House |
Same As/Similar To
SB3131 (Related) 2023-10-25 - Read twice and referred to the Committee on Finance.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/5539/all-info |
Text | https://www.congress.gov/118/bills/hr5539/BILLS-118hr5539ih.pdf |